期刊文献+

氧化应激与血压和高血压发病关系的研究 被引量:5

Oxidative Stress in Relation to Blood Pressure and Hypertension
下载PDF
导出
摘要 目的研究血清超氧化物歧化酶(SOD)、丙二醛(MDA)、尿酸(UA)与血压和高血压患病的关系.方法从2010年5月至7月来健康体检的随机选择506名,检测其SOD、MDA和UA,使用SAS 9.13统计软件进行数据库管理和统计分析.结果与血压正常者相比,高血压患者的SOD活性显著降低(P<0.01),而MDA、UA水平则明显升高(P<0.05).Pearson相关性分析发现SOD活性与血压、UA呈负相关(P<0.01),而MDA与血压、UA呈正相关(P<0.05).按照SOD、MDA的三分位数进行分组,在调整协变量后,SOD低组、中组和高组之间收缩压(Ptrend=0.02)和舒张压(Ptrend=0.04)差别均有统计学意义(P<0.05),高组的血压低于低组;MDA低组、中组和高组之间收缩压(Ptrend=0.01)和舒张压(Ptrend=0.003)差别均有统计学意义(P<0.05),高组的血压显著高于低组.结论高血压患者存在氧化和抗氧化能力失衡,氧化应激可能在高血压的发病过程中起一定的作用. Objectives To investigate the associations of serum superoxide dismutase ( SOD) , malondialdehyde (MDA), and uric acid (UA) with blood pressure and the prevalence of hypertension in a Chinese population. Methods We measured serum superoxide dismutase (SOD), malondialdehyde (MDA) and uric acid (UA) in 506 randomly selected participants. For database management and statistical analysis, we used the SAS 9.13 Software. Results Compared with normotensive participants, hypertensive patients had significantly lower serum levels of superoxide dismutase activity ( =0.0002), and higher serum levels of malondialdehyde and uric acid ( 〈0.05) .Univariate analysis indicated that serum superoxide dismutase activity was negatively associated with blood pressure, and serum levels of uric acid (P 0.0001);while serum levels of malondialdehyde was positively associated with blood pressure, and serum levels of uric acid (P 0.05) . There was significant difference in systolic (Ptrend=0.02) and diastolic blood pressure (Ptrend=0.04) between three groups defined by tertiles of serum levels of superoxide dismutase, with a lower blood pressure in the highest tertile than in the lowest tertile. Furthermore, the systolic (Ptrend=0.01) and diastolic blood pressure (Ptrend=0.003) in the highest tertile, which defied by the serum levels of malondialdehyde, were significantly higher than those in the lowest tertile. Conclusions Hypertensive patients have a disturbed oxidative and anti-oxidative balance. Oxidative stress may play a role in the pathogenesis of hypertension in Chinese.
出处 《昆明医科大学学报》 CAS 2013年第10期76-80,共5页 Journal of Kunming Medical University
基金 国家自然科学基金资助项目(30960137) 云南省教育厅科研基金资助项目(2010J051)
关键词 氧化应激 血压 高血压 超氧化物歧化酶 丙二醛 Oxidative stress Blood pressure Hypertension Superoxide dismutase Malondialdehyde
  • 相关文献

参考文献15

  • 1KHULLAR M,RELAN V,SBERAWAT BS,et al. Antioxi-dant activities and oxidative stress by products in humanhypertention [j]. Hypertention,2004,43(2):7 - 8.
  • 2王迪挦,金惠铭.氧化应激与疾病.人体病理生理学[M].第3版.北京:人民卫生出版社,2008:29.
  • 3CALLERA G E,TOSTES R C,Y0GI A,et al. Endothe-lin-1-induced oxidative stress in DOCA-salt hypertensioninvolves NADPH-oxidase-independent mechanisms [J].Clin Sci (Lond),2006,110(2):243-253.
  • 4RANCOUR! M E,RODRIGUE M E,AGHARAZII M,etal. Role of oxidative stress in erythropoie tin-induced hy-pertension in uremic rats [j]. Am J Hypertens,2010,23(3):314-320.
  • 5HULSMANS M,HOLVOET P. The vicious circle betweenoxidative stress and inflammation in atherosclerosis [j]. Jcell Mol Med,2010,14( 1) : 70-78.
  • 6王晓.高血压与高尿酸血症的相关性分析[J].当代医学,2008,14(6):50-51. 被引量:9
  • 7党爱民,刘国仗.尿酸与心血管事件[J].中华心血管病杂志,2003,31(6):478-480. 被引量:244
  • 8段艳杰,张辉,郑永刚.原发性高血压患者血清SOD和MDA及NO检测的临床意义[J].实用医技杂志,2006,13(11):1856-1857. 被引量:8
  • 9HARRISON D G,G0NG0RA M C. Oxidative stress andhypertension [J]. Med Clin North Am ,2009,93 (3): 621 -635.
  • 10CHRISSOBOLIS S,DIDION S P,KINZENBAW D A,et al.Glutathione peroxidase-1 plays a major role in protectingagainst angiotensin II-induced vascular dysfunction [J].Hypertension,2008,51(4 ):872 - 877.

二级参考文献36

  • 1丁国宪,刘超.老年高尿酸血症与心血管疾病[J].实用老年医学,2006,20(1):3-5. 被引量:13
  • 2杨明功,章秋,郭延云.老年高尿酸血症与糖尿病[J].实用老年医学,2006,20(1):8-10. 被引量:23
  • 3殷长春,范兰凤,张国惠,植中敬.高血压患者血尿酸水平变化临床观察[J].实用临床医学(江西),2006,7(10):12-12. 被引量:5
  • 4Gertler MM, Garn SM, Levine SA. Serum Uric acid in relation to age and physique in health and in coronary heart disease. Ann Intern Med, 1951,34 : 1421-1431.
  • 5Beard Jt. Serum uric acid and coronary heart disease. Am Heart J,1983,106:397-400.
  • 6Alderman MH, Cohen H, Madhavan S, et al. Serum uric acid and cardiovascular events in successfully treated hypertensive patients.Hypertension, 1999,34 : 144-150.
  • 7Bickel C, Rupprecht HI, Blankenberg S, et al. Serum uric acid as an independent predictor of mortality in patients with angiographical]y proven coronary artery disease. Am J Cardiol, 2002,89:12-17.
  • 8Brand FN, McGee DL, Kannel WB, et al. Hyperuricemia as a risk factor of coronary heart disease: The Framingham Study. Am J Epidemiol, 1985,121 : 11 -18.
  • 9Bonora E, Targher G, Zenete MB, et al. Relationship of uric acid concentration to cardiovascular risk factors in young men. Role of obesity and central fat distribution. The Verona Young Men Atheroaclerosis Risk Factors Study. Int J Obes Relat Metab Disord,1996,20:975-980.
  • 10Rathmann W, Funkhouser E, Dyer R, et al. Relations of hyperuricemia with the various components of the insulin resistance syndrome in young black and white adults: the CARDIA study.Coronary Artery Risk Development in Young Adults. Ann Epidemiol, 1998,8:250-261.

共引文献258

同被引文献65

  • 1蔡思宇,徐耕,施育平,傅国胜,单江.血管紧张素转换酶及血管紧张素原基因多态性与高血压左室肥厚的相关研究[J].中华急诊医学杂志,2005,14(4):323-327. 被引量:6
  • 2Migdal C, Serres M. Reactive oxygen species and oxidative stress [J]. Med Sci(Paris) ,2011,27 (4) :405-412.
  • 3Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease [J]. Am J Cardiol, 1983,51(3) :606.
  • 4Tousoulis D, Psahopoulou T,Androulakis E, et al. Oxidative stress and early atherosclerosis: novel antioxidant treat-ment [J]. Cardiovasc Drugs Ther,2015, 29( 1 ) : 75-88.
  • 5Lushchak VI. Free radicals, reactive oxygen species, oxidative stress and its classification [J]. Chem Biol Interact, 2014,224(C) : 164-175.
  • 6Kim C, Cha Y N. Taurine chloramine produced from taurine under inflammation provides anti-inflammatory and eytopro- tective effects[J]. Amino Acids,2014,46(1) :89-100.
  • 7De Luca A,Pierno S, Camerino D C. Taurine: the appeal of a safe amino acid for skeletal muscle disorders[J]. J Transl Med,2015,13(1) :243.
  • 8Wojcik O P, Koenig K L, Zeleniuch-Jacquotte A, et al. Serum taurine and risk of coronary heart disease: a prospective,nes- ted case-control study[J]. Eur J Nutr,2013,52(1) :169-178.
  • 9Nagai K, Fukuno S, Oda A, et al. Protective effects of taurineon doxorubicin-induced acute hepatotoxicity through suppres- sion of oxidative stress and apoptotic responses[J]. Anticancer Drugs,2016,27(1) : 17-23.
  • 10Maia A R,Batista T M,Victorio J A,et al. Taurine supplemen- tation reduces blood pressure and prevents endothelial dys- function and oxidative stress in post-weaning protein-restricted rats[J]. PLoS One,2014,9(8) :e105851.

引证文献5

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部